Author

Mei Xue

Institution: BeOne Medicines (Switzerland)

Observed institution: BeOne Medicines (Switzerland)

ORCID: 0009-0008-8087-1143

Observed ORCID: 0009-0008-8087-1143

OpenAlex ID: A5148658585

Real-world treatment patterns of bruton tyrosine kinase inhibitors (BTKi) in patients with mantle cell lymphoma (MCL) in community oncology practices in the United States (US).

2023 · Bijal D. Shah, Mei Xue, et al. · Journal of Clinical Oncology · 2

A Meta-analysis Investigating Response Rates with Continuous Bruton Tyrosine Kinase Inhibitor Monotherapies in the Treatment of B Cell Lymphomas

2026 · Pier Luigi Zinzani, Rhys Williams, et al. · Oncology and Therapy · 1

POSTER: IBCL-291: Patterns of Treatment Utilization and Sequencing Across Lines of Therapy inWaldenström Macroglobulinemia: Real-World Evidence From the United States

2026 · Jorge J Castillo, Sheeba Koshy Thomas, et al. · Clinical Lymphoma Myeloma & Leukemia

CLL-476: Real-World Comparative Analysis of Treatment Discontinuation With Covalent Bruton Tyrosine Kinase Inhibitors in First-Line Chronic Lymphocytic Leukemia

2026 · Nakhle Saba, Erin Mulvey, et al. · Clinical Lymphoma Myeloma & Leukemia

CLL-169: Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

2026 · Michael Fradley, Daniel Addison, et al. · Clinical Lymphoma Myeloma & Leukemia

IBCL-291: Patterns of Treatment Utilization and Sequencing Across Lines of Therapy in Waldenström Macroglobulinemia: Real-World Evidence From the United States

2026 · Jorge J Castillo, Sheeba Koshy Thomas, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: CLL-476: Real-World Comparative Analysis of Treatment Discontinuation With Covalent Bruton Tyrosine Kinase Inhibitors in First-Line Chronic Lymphocytic Leukemia

2026 · Nakhle Saba, Erin Mulvey, et al. · Clinical Lymphoma Myeloma & Leukemia

POSTER: CLL-169: Real-World Impact of Atrial Fibrillation on Cardiovascular Outcomes and Healthcare Resource Utilization in Patients With Chronic Lymphocytic Leukemia

2026 · Michael Fradley, Daniel Addison, et al. · Clinical Lymphoma Myeloma & Leukemia

Real-world treatment utilization, sequencing patterns, and healthcare resource utilization in Waldenström macroglobulinemia (WM).

2026 · Jorge Julio Castillo, Qianhong Fu, et al. · Journal of Clinical Oncology

Real-world impact of atrial fibrillation (AFib) on cardiovascular (CV) outcomes and healthcare resource utilization (HCRU) in patients with chronic lymphocytic leukemia (CLL).

2026 · Michael Fradley, Daniel Addison, et al. · Journal of Clinical Oncology

Real‐World Treatment Patterns and Healthcare Resource Utilization of Bruton Tyrosine Kinase Inhibitors for the Treatment of Mantle Cell Lymphoma in the United States

2026 · Bijal Shah, Mei Xue, et al. · Hematological Oncology

P1110: Real-world Treatment Patterns of Bruton Tyrosine Kinase Inhibitors (btki) in Patients With Mantle Cell Lymphoma (mcl) in Community Oncology Practices in the United States (us)

2023 · Bijal Shah, Mei Xue, et al. · HemaSphere

Works count: 12

Citation count: 3

H-index: 1

I10-index: